Clinical Trials Browser

INDUSTRY × Expanded_access × Nivolumab × Clear all

NCT06590480 2025-12-18

RPL-EAP-001

No longer available

Melanoma

NCT03126643 2021-11-29

Expanded Access to Nivolumab (Opdivo)

Approved for marketing

Neoplasms

NCT02475382 2020-11-27

CheckMate 169

No longer available

Squamous Non-Small Cell Lung Cancer

NCT02186249 2017-02-08

CheckMate218

No longer available

Melanoma